If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
<br /> SPECIAL ISSUE<br /> <br /> November/December 2011<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> THE FORUM FORTHE INDUSTRY EXECUTIVE<br /> YEAR in<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> WHAT IS<br /> YOUR BRAND'S<br /> DIGITAL<br /> INDEX?<br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> <br /> TAKE THE QUIZ NOW<br /> What's this? For more info go to<br /> adiffpersp<a title="PharmaVOICE | Nov/Dec 2011 page 1" href="http://viewer.zmags.com/publication/7e0af12c?page=1">SPECIAL ISSUENovember/December 2011</a> SPECIAL ISSUENovember/December 2011<a title="PharmaVOICE | Nov/Dec 2011 page 2" href="http://viewer.zmags.com/publication/7e0af12c?page=2">Patented medicines deservepatented promotional s</a> Patented medicines deservepatented promotional s<a title="PharmaVOICE | Nov/Dec 2011 page 3" href="http://viewer.zmags.com/publication/7e0af12c?page=3">THE FORUM FOR THE INDUSTRY EXECUTIVEVolume 11 ·</a> THE FORUM FOR THE INDUSTRY EXECUTIVEVolume 11 ·<a title="PharmaVOICE | Nov/Dec 2011 page 4" href="http://viewer.zmags.com/publication/7e0af12c?page=4">Contents... NOVEMBER/DECEMBER 2011ON THE COV</a> Contents... NOVEMBER/DECEMBER 2011ON THE COV<a title="PharmaVOICE | Nov/Dec 2011 page 5" href="http://viewer.zmags.com/publication/7e0af12c?page=5">Marketing:The Future: Digital Channels andunbra</a> Marketing:The Future: Digital Channels andunbra<a title="PharmaVOICE | Nov/Dec 2011 page 6" href="http://viewer.zmags.com/publication/7e0af12c?page=6">Exclusive Bonus ONLINE CONTENTCrystal Ball — 2</a> Exclusive Bonus ONLINE CONTENTCrystal Ball — 2<a title="PharmaVOICE | Nov/Dec 2011 page 7" href="http://viewer.zmags.com/publication/7e0af12c?page=7"></a> <a title="PharmaVOICE | Nov/Dec 2011 page 8" href="http://viewer.zmags.com/publication/7e0af12c?page=8">UpfrontAwards...» BAYER IS AWARDED BY HBABay</a> UpfrontAwards...» BAYER IS AWARDED BY HBABay<a title="PharmaVOICE | Nov/Dec 2011 page 9" href="http://viewer.zmags.com/publication/7e0af12c?page=9">Still looking forthat next bold,breakthroughid</a> Still looking forthat next bold,breakthroughid<a title="PharmaVOICE | Nov/Dec 2011 page 10" href="http://viewer.zmags.com/publication/7e0af12c?page=10">» 2012 AND BEYOND </a> » 2012 AND BEYOND <a title="PharmaVOICE | Nov/Dec 2011 page 11" href="http://viewer.zmags.com/publication/7e0af12c?page=11">decrease clinical trial costs is still a m</a> decrease clinical trial costs is still a m<a title="PharmaVOICE | Nov/Dec 2011 page 12" href="http://viewer.zmags.com/publication/7e0af12c?page=12">» 2012: CRYSTAL BALLTaren GromWhat’s Aheadfor</a> » 2012: CRYSTAL BALLTaren GromWhat’s Aheadfor<a title="PharmaVOICE | Nov/Dec 2011 page 13" href="http://viewer.zmags.com/publication/7e0af12c?page=13">5V^¯[OL:JPLUJLVM:HTWSPUN4LL[Z[OL:JPLUJLVM4LKPJPU</a> 5V^¯[OL:JPLUJLVM:HTWSPUN4LL[Z[OL:JPLUJLVM4LKPJPU<a title="PharmaVOICE | Nov/Dec 2011 page 14" href="http://viewer.zmags.com/publication/7e0af12c?page=14">2012 YEAR IN PREVIEW: </a> 2012 YEAR IN PREVIEW: <a title="PharmaVOICE | Nov/Dec 2011 page 15" href="http://viewer.zmags.com/publication/7e0af12c?page=15">PAREXEL Product Lifecycle Management Services</a> PAREXEL Product Lifecycle Management Services<a title="PharmaVOICE | Nov/Dec 2011 page 16" href="http://viewer.zmags.com/publication/7e0af12c?page=16">2012 YEAR IN PREVIEW: </a> 2012 YEAR IN PREVIEW: <a title="PharmaVOICE | Nov/Dec 2011 page 17" href="http://viewer.zmags.com/publication/7e0af12c?page=17"> </a> <a title="PharmaVOICE | Nov/Dec 2011 page 18" href="http://viewer.zmags.com/publication/7e0af12c?page=18">DIGITAL EDITION — BONUS CONTENT» 2012: CRYSTAL B</a> DIGITAL EDITION — BONUS CONTENT» 2012: CRYSTAL B<a title="PharmaVOICE | Nov/Dec 2011 page 19" href="http://viewer.zmags.com/publication/7e0af12c?page=19">DIGITAL EDITION — BONUS CONTENThealth apps </a> DIGITAL EDITION — BONUS CONTENThealth apps <a title="PharmaVOICE | Nov/Dec 2011 page 20" href="http://viewer.zmags.com/publication/7e0af12c?page=20">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 21" href="http://viewer.zmags.com/publication/7e0af12c?page=21">StudyMessagingSolutionsMessagingSolutionsStudyM</a> StudyMessagingSolutionsMessagingSolutionsStudyM<a title="PharmaVOICE | Nov/Dec 2011 page 22" href="http://viewer.zmags.com/publication/7e0af12c?page=22">» THE C-SUITE: EXECUTIVE INSIGHTSRobin Robinson</a> » THE C-SUITE: EXECUTIVE INSIGHTSRobin Robinson<a title="PharmaVOICE | Nov/Dec 2011 page 23" href="http://viewer.zmags.com/publication/7e0af12c?page=23">ROBERT S. EPSTEIN, M.D., is President ofUnite</a> ROBERT S. EPSTEIN, M.D., is President ofUnite<a title="PharmaVOICE | Nov/Dec 2011 page 24" href="http://viewer.zmags.com/publication/7e0af12c?page=24">2012 YEAR IN PREVIEW:and a WPP c</a> 2012 YEAR IN PREVIEW:and a WPP c<a title="PharmaVOICE | Nov/Dec 2011 page 25" href="http://viewer.zmags.com/publication/7e0af12c?page=25">time the market. Additionally, focusing on the co</a> time the market. Additionally, focusing on the co<a title="PharmaVOICE | Nov/Dec 2011 page 26" href="http://viewer.zmags.com/publication/7e0af12c?page=26">2012 YEAR IN PREVIEW:fund ongoin</a> 2012 YEAR IN PREVIEW:fund ongoin<a title="PharmaVOICE | Nov/Dec 2011 page 27" href="http://viewer.zmags.com/publication/7e0af12c?page=27"> The success of a company will be based on </a> The success of a company will be based on <a title="PharmaVOICE | Nov/Dec 2011 page 28" href="http://viewer.zmags.com/publication/7e0af12c?page=28">» THE C-SUITE: CORPORATE STRATEGIESTaren GromN</a> » THE C-SUITE: CORPORATE STRATEGIESTaren GromN<a title="PharmaVOICE | Nov/Dec 2011 page 29" href="http://viewer.zmags.com/publication/7e0af12c?page=29">physician with a wealthy clientele that is</a> physician with a wealthy clientele that is<a title="PharmaVOICE | Nov/Dec 2011 page 30" href="http://viewer.zmags.com/publication/7e0af12c?page=30">2012 YEAR IN PREVIEW:SOUND BITES FROM THE FI</a> 2012 YEAR IN PREVIEW:SOUND BITES FROM THE FI<a title="PharmaVOICE | Nov/Dec 2011 page 31" href="http://viewer.zmags.com/publication/7e0af12c?page=31">periodic regulatory issues. For example, auditpr</a> periodic regulatory issues. For example, auditpr<a title="PharmaVOICE | Nov/Dec 2011 page 32" href="http://viewer.zmags.com/publication/7e0af12c?page=32">2012 YEAR IN PREVIEW:to be relearned, be</a> 2012 YEAR IN PREVIEW:to be relearned, be<a title="PharmaVOICE | Nov/Dec 2011 page 33" href="http://viewer.zmags.com/publication/7e0af12c?page=33">Turn up theCan your agency really enhance t</a> Turn up theCan your agency really enhance t<a title="PharmaVOICE | Nov/Dec 2011 page 34" href="http://viewer.zmags.com/publication/7e0af12c?page=34">2012 YEAR IN PREVIEW:coverage. Howeve</a> 2012 YEAR IN PREVIEW:coverage. Howeve<a title="PharmaVOICE | Nov/Dec 2011 page 35" href="http://viewer.zmags.com/publication/7e0af12c?page=35">MSL programs as unique as your product.You</a> MSL programs as unique as your product.You<a title="PharmaVOICE | Nov/Dec 2011 page 36" href="http://viewer.zmags.com/publication/7e0af12c?page=36">» R&D: INNOVATIONDenise MyshkoBuilding a Cultur</a> » R&D: INNOVATIONDenise MyshkoBuilding a Cultur<a title="PharmaVOICE | Nov/Dec 2011 page 37" href="http://viewer.zmags.com/publication/7e0af12c?page=37">Research & Development “scientific co</a> Research & Development “scientific co<a title="PharmaVOICE | Nov/Dec 2011 page 38" href="http://viewer.zmags.com/publication/7e0af12c?page=38">2012 YEAR IN PREVIEW:Pharma Advisors, </a> 2012 YEAR IN PREVIEW:Pharma Advisors, <a title="PharmaVOICE | Nov/Dec 2011 page 39" href="http://viewer.zmags.com/publication/7e0af12c?page=39">Challenges of Open Innovation Dr. Cooper say</a> Challenges of Open Innovation Dr. Cooper say<a title="PharmaVOICE | Nov/Dec 2011 page 40" href="http://viewer.zmags.com/publication/7e0af12c?page=40">2012 YEAR IN PREVIEW:“ We believe in the </a> 2012 YEAR IN PREVIEW:“ We believe in the <a title="PharmaVOICE | Nov/Dec 2011 page 41" href="http://viewer.zmags.com/publication/7e0af12c?page=41">Research & Developmentaddressed througho</a> Research & Developmentaddressed througho<a title="PharmaVOICE | Nov/Dec 2011 page 42" href="http://viewer.zmags.com/publication/7e0af12c?page=42">DIGITAL EDITION — BONUS CONTENT» R&D: PIPELINE P</a> DIGITAL EDITION — BONUS CONTENT» R&D: PIPELINE P<a title="PharmaVOICE | Nov/Dec 2011 page 43" href="http://viewer.zmags.com/publication/7e0af12c?page=43">DIGITAL EDITION — BONUS CONTENTd</a> DIGITAL EDITION — BONUS CONTENTd<a title="PharmaVOICE | Nov/Dec 2011 page 44" href="http://viewer.zmags.com/publication/7e0af12c?page=44">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 45" href="http://viewer.zmags.com/publication/7e0af12c?page=45">DIGITAL EDITION — BONUS CONTENTtions</a> DIGITAL EDITION — BONUS CONTENTtions<a title="PharmaVOICE | Nov/Dec 2011 page 46" href="http://viewer.zmags.com/publication/7e0af12c?page=46">» R&D: OUTSOURCINGDenise MyshkoStrategic Outsou</a> » R&D: OUTSOURCINGDenise MyshkoStrategic Outsou<a title="PharmaVOICE | Nov/Dec 2011 page 47" href="http://viewer.zmags.com/publication/7e0af12c?page=47">continue to ramp up, and it is anticipated thatt</a> continue to ramp up, and it is anticipated thatt<a title="PharmaVOICE | Nov/Dec 2011 page 48" href="http://viewer.zmags.com/publication/7e0af12c?page=48">2012 YEAR IN PREVIEW:Building Partnerships</a> 2012 YEAR IN PREVIEW:Building Partnerships<a title="PharmaVOICE | Nov/Dec 2011 page 49" href="http://viewer.zmags.com/publication/7e0af12c?page=49">Research & Development caphaee“ The c</a> Research & Development caphaee“ The c<a title="PharmaVOICE | Nov/Dec 2011 page 50" href="http://viewer.zmags.com/publication/7e0af12c?page=50">DIGITAL EDITION — BONUS CONTENT» R&D: OUTSOURCIN</a> DIGITAL EDITION — BONUS CONTENT» R&D: OUTSOURCIN<a title="PharmaVOICE | Nov/Dec 2011 page 51" href="http://viewer.zmags.com/publication/7e0af12c?page=51">DIGITAL EDITION — BONUS CONTENT</a> DIGITAL EDITION — BONUS CONTENT<a title="PharmaVOICE | Nov/Dec 2011 page 52" href="http://viewer.zmags.com/publication/7e0af12c?page=52">» R&D: REGULATORYDenise MyshkoGLOBAL Regulator</a> » R&D: REGULATORYDenise MyshkoGLOBAL Regulator<a title="PharmaVOICE | Nov/Dec 2011 page 53" href="http://viewer.zmags.com/publication/7e0af12c?page=53">The FDA's Safety InitiativeThe Food and Drug A</a> The FDA's Safety InitiativeThe Food and Drug A<a title="PharmaVOICE | Nov/Dec 2011 page 54" href="http://viewer.zmags.com/publication/7e0af12c?page=54">2012 YEAR IN PREVIEW:through life-cycle dev</a> 2012 YEAR IN PREVIEW:through life-cycle dev<a title="PharmaVOICE | Nov/Dec 2011 page 55" href="http://viewer.zmags.com/publication/7e0af12c?page=55">between key stakeholders, thereby encourag-ing </a> between key stakeholders, thereby encourag-ing <a title="PharmaVOICE | Nov/Dec 2011 page 56" href="http://viewer.zmags.com/publication/7e0af12c?page=56">DIGITAL EDITION — BONUS CONTENT» R&D: REGULATORY</a> DIGITAL EDITION — BONUS CONTENT» R&D: REGULATORY<a title="PharmaVOICE | Nov/Dec 2011 page 57" href="http://viewer.zmags.com/publication/7e0af12c?page=57">DIGITAL EDITION — BONUS CONTENTtheir unde</a> DIGITAL EDITION — BONUS CONTENTtheir unde<a title="PharmaVOICE | Nov/Dec 2011 page 58" href="http://viewer.zmags.com/publication/7e0af12c?page=58">» R&D: DEVICESDenise MyshkoThe DRUG-DEVICEConu</a> » R&D: DEVICESDenise MyshkoThe DRUG-DEVICEConu<a title="PharmaVOICE | Nov/Dec 2011 page 59" href="http://viewer.zmags.com/publication/7e0af12c?page=59">Research & Development “We place our d</a> Research & Development “We place our d<a title="PharmaVOICE | Nov/Dec 2011 page 60" href="http://viewer.zmags.com/publication/7e0af12c?page=60">2012 YEAR IN PREVIEW:and a drug need to be </a> 2012 YEAR IN PREVIEW:and a drug need to be <a title="PharmaVOICE | Nov/Dec 2011 page 61" href="http://viewer.zmags.com/publication/7e0af12c?page=61">Preview</a> Preview<a title="PharmaVOICE | Nov/Dec 2011 page 62" href="http://viewer.zmags.com/publication/7e0af12c?page=62">» MARKETING: MEDIA MIXRobin RobinsonMedia Mix </a> » MARKETING: MEDIA MIXRobin RobinsonMedia Mix <a title="PharmaVOICE | Nov/Dec 2011 page 63" href="http://viewer.zmags.com/publication/7e0af12c?page=63">Marketing “The result is that innovative </a> Marketing “The result is that innovative <a title="PharmaVOICE | Nov/Dec 2011 page 64" href="http://viewer.zmags.com/publication/7e0af12c?page=64">:“ Online resources today ena</a> :“ Online resources today ena<a title="PharmaVOICE | Nov/Dec 2011 page 65" href="http://viewer.zmags.com/publication/7e0af12c?page=65">MarketingIt starts with an idea. IDEAS FIRSTWe</a> MarketingIt starts with an idea. IDEAS FIRSTWe<a title="PharmaVOICE | Nov/Dec 2011 page 66" href="http://viewer.zmags.com/publication/7e0af12c?page=66">decline in the in-dustry (but whatwasn't </a> decline in the in-dustry (but whatwasn't <a title="PharmaVOICE | Nov/Dec 2011 page 67" href="http://viewer.zmags.com/publication/7e0af12c?page=67">PreviewCONFERENCE&EXHIBITIONwith the Phys</a> PreviewCONFERENCE&EXHIBITIONwith the Phys<a title="PharmaVOICE | Nov/Dec 2011 page 68" href="http://viewer.zmags.com/publication/7e0af12c?page=68">2012 YEAR IN PREVIEW: Online resources </a> 2012 YEAR IN PREVIEW: Online resources <a title="PharmaVOICE | Nov/Dec 2011 page 69" href="http://viewer.zmags.com/publication/7e0af12c?page=69">to better understand disease conditions andthera</a> to better understand disease conditions andthera<a title="PharmaVOICE | Nov/Dec 2011 page 70" href="http://viewer.zmags.com/publication/7e0af12c?page=70">2012 YEAR IN PREVIEW: “As pharmaceutical </a> 2012 YEAR IN PREVIEW: “As pharmaceutical <a title="PharmaVOICE | Nov/Dec 2011 page 71" href="http://viewer.zmags.com/publication/7e0af12c?page=71">mation, especially early in the purchase cycle,c</a> mation, especially early in the purchase cycle,c<a title="PharmaVOICE | Nov/Dec 2011 page 72" href="http://viewer.zmags.com/publication/7e0af12c?page=72">DIGITAL EDITION — BONUS CONTENT» MARKETING: MARK</a> DIGITAL EDITION — BONUS CONTENT» MARKETING: MARK<a title="PharmaVOICE | Nov/Dec 2011 page 73" href="http://viewer.zmags.com/publication/7e0af12c?page=73">DIGITAL EDITION — BONUS CONTENTMarketing</a> DIGITAL EDITION — BONUS CONTENTMarketing<a title="PharmaVOICE | Nov/Dec 2011 page 74" href="http://viewer.zmags.com/publication/7e0af12c?page=74">DIGITAL EDITION — BONUS CONTENTtegrate patie</a> DIGITAL EDITION — BONUS CONTENTtegrate patie<a title="PharmaVOICE | Nov/Dec 2011 page 75" href="http://viewer.zmags.com/publication/7e0af12c?page=75">DIGITAL EDITION — BONUS CONTENTWorldCancer</a> DIGITAL EDITION — BONUS CONTENTWorldCancer<a title="PharmaVOICE | Nov/Dec 2011 page 76" href="http://viewer.zmags.com/publication/7e0af12c?page=76">» MARKETING: SOCIAL MEDIARobin RobinsonSOCIAL </a> » MARKETING: SOCIAL MEDIARobin RobinsonSOCIAL <a title="PharmaVOICE | Nov/Dec 2011 page 77" href="http://viewer.zmags.com/publication/7e0af12c?page=77">“ Pharma dmedia to enbut rather iton social me</a> “ Pharma dmedia to enbut rather iton social me<a title="PharmaVOICE | Nov/Dec 2011 page 78" href="http://viewer.zmags.com/publication/7e0af12c?page=78">“ Much of the industry treats socialmedia as a </a> “ Much of the industry treats socialmedia as a <a title="PharmaVOICE | Nov/Dec 2011 page 79" href="http://viewer.zmags.com/publication/7e0af12c?page=79">Industry Misperceptions One common mispercept</a> Industry Misperceptions One common mispercept<a title="PharmaVOICE | Nov/Dec 2011 page 80" href="http://viewer.zmags.com/publication/7e0af12c?page=80">DIGITAL EDITION — BONUS CONTENT» MARKETING: PRR</a> DIGITAL EDITION — BONUS CONTENT» MARKETING: PRR<a title="PharmaVOICE | Nov/Dec 2011 page 81" href="http://viewer.zmags.com/publication/7e0af12c?page=81">DIGITAL EDITION — BONUS CONTENT“ Public relati</a> DIGITAL EDITION — BONUS CONTENT“ Public relati<a title="PharmaVOICE | Nov/Dec 2011 page 82" href="http://viewer.zmags.com/publication/7e0af12c?page=82">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 83" href="http://viewer.zmags.com/publication/7e0af12c?page=83">DIGITAL EDITION — BONUS CONTENTPreview</a> DIGITAL EDITION — BONUS CONTENTPreview<a title="PharmaVOICE | Nov/Dec 2011 page 84" href="http://viewer.zmags.com/publication/7e0af12c?page=84">DIGITAL EDITION — BONUS CONTENT» MARKETING: MARK</a> DIGITAL EDITION — BONUS CONTENT» MARKETING: MARK<a title="PharmaVOICE | Nov/Dec 2011 page 85" href="http://viewer.zmags.com/publication/7e0af12c?page=85">DIGITAL EDITION — BONUS CONTENTMarketing“ Sur</a> DIGITAL EDITION — BONUS CONTENTMarketing“ Sur<a title="PharmaVOICE | Nov/Dec 2011 page 86" href="http://viewer.zmags.com/publication/7e0af12c?page=86">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 87" href="http://viewer.zmags.com/publication/7e0af12c?page=87">DIGITAL EDITION — BONUS CONTENT10fMitigation</a> DIGITAL EDITION — BONUS CONTENT10fMitigation<a title="PharmaVOICE | Nov/Dec 2011 page 88" href="http://viewer.zmags.com/publication/7e0af12c?page=88">DIGITAL EDITION — BONUS CONTENT» MARKETING: PUBL</a> DIGITAL EDITION — BONUS CONTENT» MARKETING: PUBL<a title="PharmaVOICE | Nov/Dec 2011 page 89" href="http://viewer.zmags.com/publication/7e0af12c?page=89">DIGITAL EDITION — BONUS CONTENTwork within a</a> DIGITAL EDITION — BONUS CONTENTwork within a<a title="PharmaVOICE | Nov/Dec 2011 page 90" href="http://viewer.zmags.com/publication/7e0af12c?page=90">» MARKETING: ADVERTISINGRobin Robinson“ Withou</a> » MARKETING: ADVERTISINGRobin Robinson“ Withou<a title="PharmaVOICE | Nov/Dec 2011 page 91" href="http://viewer.zmags.com/publication/7e0af12c?page=91">longer an afterthought but is now consideredat t</a> longer an afterthought but is now consideredat t<a title="PharmaVOICE | Nov/Dec 2011 page 92" href="http://viewer.zmags.com/publication/7e0af12c?page=92">“ Digital today represents thewhole market and n</a> “ Digital today represents thewhole market and n<a title="PharmaVOICE | Nov/Dec 2011 page 93" href="http://viewer.zmags.com/publication/7e0af12c?page=93"> </a> <a title="PharmaVOICE | Nov/Dec 2011 page 94" href="http://viewer.zmags.com/publication/7e0af12c?page=94">DIGITAL EDITION — BONUS CONTENT» MARKETING: PATI</a> DIGITAL EDITION — BONUS CONTENT» MARKETING: PATI<a title="PharmaVOICE | Nov/Dec 2011 page 95" href="http://viewer.zmags.com/publication/7e0af12c?page=95">DIGITAL EDITION — BONUS CONTENTMarketing </a> DIGITAL EDITION — BONUS CONTENTMarketing <a title="PharmaVOICE | Nov/Dec 2011 page 96" href="http://viewer.zmags.com/publication/7e0af12c?page=96">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 97" href="http://viewer.zmags.com/publication/7e0af12c?page=97">DIGITAL EDITION — BONUS CONTENT</a> DIGITAL EDITION — BONUS CONTENT<a title="PharmaVOICE | Nov/Dec 2011 page 98" href="http://viewer.zmags.com/publication/7e0af12c?page=98">» SALESTaren GromSales SHIFTAs sales models </a> » SALESTaren GromSales SHIFTAs sales models <a title="PharmaVOICE | Nov/Dec 2011 page 99" href="http://viewer.zmags.com/publication/7e0af12c?page=99"> “This approach will require them to havegrea</a> “This approach will require them to havegrea<a title="PharmaVOICE | Nov/Dec 2011 page 100" href="http://viewer.zmags.com/publication/7e0af12c?page=100">2012 YEAR IN PREVIEW:SOUND BITES FROM THE FI</a> 2012 YEAR IN PREVIEW:SOUND BITES FROM THE FI<a title="PharmaVOICE | Nov/Dec 2011 page 101" href="http://viewer.zmags.com/publication/7e0af12c?page=101">accessed by physicians and patients fromwit</a> accessed by physicians and patients fromwit<a title="PharmaVOICE | Nov/Dec 2011 page 102" href="http://viewer.zmags.com/publication/7e0af12c?page=102">DIGITAL EDITION — BONUS CONTENT» SALES: BEST PRA</a> DIGITAL EDITION — BONUS CONTENT» SALES: BEST PRA<a title="PharmaVOICE | Nov/Dec 2011 page 103" href="http://viewer.zmags.com/publication/7e0af12c?page=103">DIGITAL EDITION — BONUS CONTENTSalesi</a> DIGITAL EDITION — BONUS CONTENTSalesi<a title="PharmaVOICE | Nov/Dec 2011 page 104" href="http://viewer.zmags.com/publication/7e0af12c?page=104">DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE</a> DIGITAL EDITION — BONUS CONTENT2012 YEAR IN PRE<a title="PharmaVOICE | Nov/Dec 2011 page 105" href="http://viewer.zmags.com/publication/7e0af12c?page=105">DIGITAL EDITION — BONUS CONTENTSalesEXPE</a> DIGITAL EDITION — BONUS CONTENTSalesEXPE<a title="PharmaVOICE | Nov/Dec 2011 page 106" href="http://viewer.zmags.com/publication/7e0af12c?page=106">» GLOBALTaren GromA ShrinkingWORLDGlobal reac</a> » GLOBALTaren GromA ShrinkingWORLDGlobal reac<a title="PharmaVOICE | Nov/Dec 2011 page 107" href="http://viewer.zmags.com/publication/7e0af12c?page=107">objective companies can start acting on now.Ther</a> objective companies can start acting on now.Ther<a title="PharmaVOICE | Nov/Dec 2011 page 108" href="http://viewer.zmags.com/publication/7e0af12c?page=108">2012 YEAR IN PREVIEW:SOUND BITES FROM THE </a> 2012 YEAR IN PREVIEW:SOUND BITES FROM THE <a title="PharmaVOICE | Nov/Dec 2011 page 109" href="http://viewer.zmags.com/publication/7e0af12c?page=109">second trend of coordinated global launches. Byc</a> second trend of coordinated global launches. Byc<a title="PharmaVOICE | Nov/Dec 2011 page 110" href="http://viewer.zmags.com/publication/7e0af12c?page=110">E-SolutionsCarolyn GrettonBuilding a BetterE</a> E-SolutionsCarolyn GrettonBuilding a BetterE<a title="PharmaVOICE | Nov/Dec 2011 page 111" href="http://viewer.zmags.com/publication/7e0af12c?page=111">E-SolutionsPRECISIONATEnVsVurinEgEacRcur</a> E-SolutionsPRECISIONATEnVsVurinEgEacRcur<a title="PharmaVOICE | Nov/Dec 2011 page 112" href="http://viewer.zmags.com/publication/7e0af12c?page=112">E-Solutionschannel, with the right message f</a> E-Solutionschannel, with the right message f<a title="PharmaVOICE | Nov/Dec 2011 page 113" href="http://viewer.zmags.com/publication/7e0af12c?page=113">other tablet during a face-to-face meeting inthe</a> other tablet during a face-to-face meeting inthe<a title="PharmaVOICE | Nov/Dec 2011 page 114" href="http://viewer.zmags.com/publication/7e0af12c?page=114">E-Solutions some of the detailing progra</a> E-Solutions some of the detailing progra<a title="PharmaVOICE | Nov/Dec 2011 page 115" href="http://viewer.zmags.com/publication/7e0af12c?page=115">E-Solutionscome an integral part of most phar</a> E-Solutionscome an integral part of most phar<a title="PharmaVOICE | Nov/Dec 2011 page 116" href="http://viewer.zmags.com/publication/7e0af12c?page=116"> Medidata SolutionsWorldwide79 Fifth Avenu</a> Medidata SolutionsWorldwide79 Fifth Avenu<a title="PharmaVOICE | Nov/Dec 2011 page 117" href="http://viewer.zmags.com/publication/7e0af12c?page=117"> OgilvyCommonHealthWorldwide400 Interpac</a> OgilvyCommonHealthWorldwide400 Interpac<a title="PharmaVOICE | Nov/Dec 2011 page 118" href="http://viewer.zmags.com/publication/7e0af12c?page=118">E-SolutionsHealth Outcomes Research —AN EVO</a> E-SolutionsHealth Outcomes Research —AN EVO<a title="PharmaVOICE | Nov/Dec 2011 page 119" href="http://viewer.zmags.com/publication/7e0af12c?page=119">require the same substantial evidence from ad-eq</a> require the same substantial evidence from ad-eq<a title="PharmaVOICE | Nov/Dec 2011 page 120" href="http://viewer.zmags.com/publication/7e0af12c?page=120">E-SolutionsE-SOLUTIONS:Not Just Another q</a> E-SolutionsE-SOLUTIONS:Not Just Another q<a title="PharmaVOICE | Nov/Dec 2011 page 121" href="http://viewer.zmags.com/publication/7e0af12c?page=121"></a> <a title="PharmaVOICE | Nov/Dec 2011 page 122" href="http://viewer.zmags.com/publication/7e0af12c?page=122">E-SolutionsThe Increasing Role of the Patient</a> E-SolutionsThe Increasing Role of the Patient<a title="PharmaVOICE | Nov/Dec 2011 page 123" href="http://viewer.zmags.com/publication/7e0af12c?page=123">E-SolutionsWith the constant influx of new t</a> E-SolutionsWith the constant influx of new t<a title="PharmaVOICE | Nov/Dec 2011 page 124" href="http://viewer.zmags.com/publication/7e0af12c?page=124">E-SolutionsOgilvy CommonHealth WorldwideAcco</a> E-SolutionsOgilvy CommonHealth WorldwideAcco<a title="PharmaVOICE | Nov/Dec 2011 page 125" href="http://viewer.zmags.com/publication/7e0af12c?page=125">Year-to-Date Change in Revenue by Category (May 2</a> Year-to-Date Change in Revenue by Category (May 2<a title="PharmaVOICE | Nov/Dec 2011 page 126" href="http://viewer.zmags.com/publication/7e0af12c?page=126">E-SolutionsMulti-Channel Sales Solutions:TH</a> E-SolutionsMulti-Channel Sales Solutions:TH<a title="PharmaVOICE | Nov/Dec 2011 page 127" href="http://viewer.zmags.com/publication/7e0af12c?page=127">E-Solutionsceutical sales strategy, parti</a> E-Solutionsceutical sales strategy, parti<a title="PharmaVOICE | Nov/Dec 2011 page 128" href="http://viewer.zmags.com/publication/7e0af12c?page=128">E-SolutionsOnline Investigator Training in Cli</a> E-SolutionsOnline Investigator Training in Cli<a title="PharmaVOICE | Nov/Dec 2011 page 129" href="http://viewer.zmags.com/publication/7e0af12c?page=129"></a> <a title="PharmaVOICE | Nov/Dec 2011 page 130" href="http://viewer.zmags.com/publication/7e0af12c?page=130">The CalendarINDUSTRY EVENTS ANDCONFERENCES, INC</a> The CalendarINDUSTRY EVENTS ANDCONFERENCES, INC<a title="PharmaVOICE | Nov/Dec 2011 page 131" href="http://viewer.zmags.com/publication/7e0af12c?page=131">Provocative Dialogue. Insightful Education. Purpo</a> Provocative Dialogue. Insightful Education. Purpo<a title="PharmaVOICE | Nov/Dec 2011 page 132" href="http://viewer.zmags.com/publication/7e0af12c?page=132">DIGITAL EDITION — BONUS CONTENTNOV16</a> DIGITAL EDITION — BONUS CONTENTNOV16<a title="PharmaVOICE | Nov/Dec 2011 page 133" href="http://viewer.zmags.com/publication/7e0af12c?page=133">DIGITAL EDITION — BONUS CONTENTLondon</a> DIGITAL EDITION — BONUS CONTENTLondon<a title="PharmaVOICE | Nov/Dec 2011 page 134" href="http://viewer.zmags.com/publication/7e0af12c?page=134">DIGITAL EDITION — BONUS CONTENTThe Calendar</a> DIGITAL EDITION — BONUS CONTENTThe Calendar<a title="PharmaVOICE | Nov/Dec 2011 page 135" href="http://viewer.zmags.com/publication/7e0af12c?page=135">DIGITAL EDITION — BONUS CONTENTDEC7</a> DIGITAL EDITION — BONUS CONTENTDEC7<a title="PharmaVOICE | Nov/Dec 2011 page 136" href="http://viewer.zmags.com/publication/7e0af12c?page=136">DIGITAL EDITION — BONUS CONTENT</a> DIGITAL EDITION — BONUS CONTENT<a title="PharmaVOICE | Nov/Dec 2011 page 137" href="http://viewer.zmags.com/publication/7e0af12c?page=137">11 THANNUALDigital Marketing InnovatorsDRIVIN</a> 11 THANNUALDigital Marketing InnovatorsDRIVIN<a title="PharmaVOICE | Nov/Dec 2011 page 138" href="http://viewer.zmags.com/publication/7e0af12c?page=138">DIGITAL EDITION — BONUS CONTENTWhat's NewNEW </a> DIGITAL EDITION — BONUS CONTENTWhat's NewNEW <a title="PharmaVOICE | Nov/Dec 2011 page 139" href="http://viewer.zmags.com/publication/7e0af12c?page=139">DIGITAL EDITION — BONUS CONTENT McC</a> DIGITAL EDITION — BONUS CONTENT McC<a title="PharmaVOICE | Nov/Dec 2011 page 140" href="http://viewer.zmags.com/publication/7e0af12c?page=140">DIGITAL EDITION — BONUS CONTENTSocial Media </a> DIGITAL EDITION — BONUS CONTENTSocial Media <a title="PharmaVOICE | Nov/Dec 2011 page 141" href="http://viewer.zmags.com/publication/7e0af12c?page=141">DIGITAL EDITION — BONUS CONTENTSocial MediaTEC</a> DIGITAL EDITION — BONUS CONTENTSocial MediaTEC<a title="PharmaVOICE | Nov/Dec 2011 page 142" href="http://viewer.zmags.com/publication/7e0af12c?page=142">DIGITAL EDITION — BONUS CONTENTTools of the Tr</a> DIGITAL EDITION — BONUS CONTENTTools of the Tr<a title="PharmaVOICE | Nov/Dec 2011 page 143" href="http://viewer.zmags.com/publication/7e0af12c?page=143">DIGITAL EDITION — BONUS CONTENTTools of the Trad</a> DIGITAL EDITION — BONUS CONTENTTools of the Trad<a title="PharmaVOICE | Nov/Dec 2011 page 144" href="http://viewer.zmags.com/publication/7e0af12c?page=144">DIGITAL EDITION — BONUS CONTENTPharma TraxSALE</a> DIGITAL EDITION — BONUS CONTENTPharma TraxSALE<a title="PharmaVOICE | Nov/Dec 2011 page 145" href="http://viewer.zmags.com/publication/7e0af12c?page=145">DIGITAL EDITION — BONUS CONTENTPharma Trax</a> DIGITAL EDITION — BONUS CONTENTPharma Trax<a title="PharmaVOICE | Nov/Dec 2011 page 146" href="http://viewer.zmags.com/publication/7e0af12c?page=146">DIGITAL EDITION — BONUS CONTENTTalent PoolEXE</a> DIGITAL EDITION — BONUS CONTENTTalent PoolEXE<a title="PharmaVOICE | Nov/Dec 2011 page 147" href="http://viewer.zmags.com/publication/7e0af12c?page=147">DIGITAL EDITION — BONUS CONTENT </a> DIGITAL EDITION — BONUS CONTENT <a title="PharmaVOICE | Nov/Dec 2011 page 148" href="http://viewer.zmags.com/publication/7e0af12c?page=148">DIGITAL EDITION — BONUS CONTENTTalent Pool</a> DIGITAL EDITION — BONUS CONTENTTalent Pool<a title="PharmaVOICE | Nov/Dec 2011 page 149" href="http://viewer.zmags.com/publication/7e0af12c?page=149">DIGITAL EDITION — BONUS CONTENT </a> DIGITAL EDITION — BONUS CONTENT <a title="PharmaVOICE | Nov/Dec 2011 page 150" href="http://viewer.zmags.com/publication/7e0af12c?page=150">DIGITAL EDITION — BONUS CONTENTTalent Pool</a> DIGITAL EDITION — BONUS CONTENTTalent Pool<a title="PharmaVOICE | Nov/Dec 2011 page 151" href="http://viewer.zmags.com/publication/7e0af12c?page=151"> New Paradigms to Fund& Move Drug DevelopmentT</a> New Paradigms to Fund& Move Drug DevelopmentT<a title="PharmaVOICE | Nov/Dec 2011 page 152" href="http://viewer.zmags.com/publication/7e0af12c?page=152">The LAST WordTaking Digital Communications to</a> The LAST WordTaking Digital Communications to<a title="PharmaVOICE | Nov/Dec 2011 page 153" href="http://viewer.zmags.com/publication/7e0af12c?page=153">PATS ON THE BACK,HANDSHAKES, HIGH-FIVES.STANDA</a> PATS ON THE BACK,HANDSHAKES, HIGH-FIVES.STANDA<a title="PharmaVOICE | Nov/Dec 2011 page 154" href="http://viewer.zmags.com/publication/7e0af12c?page=154"> Get away No, this is not a fantasy island. </a> Get away No, this is not a fantasy island.